CL-H1T

CL-H1T – is a novel, fixed dose formulation of a triptan combined with an anti-emetic in a proprietary release technology.  CL-H1T will be investigated for treatment of migraine headaches and the reduction or elimination of Migraine Induced Nausea & Vomiting (MINV).